What is driving IHL.AX stock’s heavy pre‑market volume today?

Pre‑market volume for IHL.AX stock rose on increased visibility from ADR mentions and renewed attention to Incannex’s clinical pipeline. High volume reflects speculation, possible retail flow, and cross‑market interest rather than a confirmed earnings catalyst

What valuation metrics should I watch for IHL.AX stock?

Track EPS (**-1.30**), PE (negative), PB (**0.75**), cash per share (**A$0.02171**) and price averages (**50‑day A$0.065**, **200‑day A$0.103**). R&D spending and cash runway matter more than sales for this small clinical company

What is Meyka AI’s recommendation and score for IHL.AX stock?

Meyka AI rates IHL.AX with a score out of 100: **60.92** giving Grade **B** with a **HOLD** suggestion. The grade factors benchmark, sector, financial growth, key metrics, and analyst inputs

How should traders manage risk when trading IHL.AX stock?

Given IHL.AX stock’s high intraday volume and volatility, use tight position sizing, stop losses, and limit orders. Watch support at **A$0.041** and resistance near **A$0.051**, and avoid oversized positions relative to liquidity

AU Stocks

IHL.AX Incannex ASX A$0.041 pre-market 23 Jan 2026: heavy volume signals interest

ByHuzaifa Zahoor January 22, 2026January 22, 2026

IHL.AX stock opens pre-market at A$0.041 on 23 Jan 2026 with unusually high trading volume. The ASX-listed Incannex Healthcare Limited shows 61,360,016 shares traded versus an average of 6,427,691, a relative volume of 9.55. That jump follows renewed interest in the company’s clinical pipeline and cross‑listing mentions, and it puts IHL.AX stock at the centre of today’s most active list. Traders should watch liquidity, short‑term support at A$0.041, and potential catalyst dates for news flow